wersja polska  
Mediton - Publishing House
Start page  Journals  Books  Conferences  News  Mediton  Contact   
   Journals
print this
   Allergy Asthma Immunology - archive  

Allergy Asthma Immunology
     Archive
     Editorial staff
     Editorial board
     For authors
     Subscription
Otorhinolaryngology
Allergology Review



 Search in articles:
  Authority of Polish Society of Allergology




vol 11. no 4. December 2006  
 TABLE OF CONTENT

 Postgraduate education
Standards in the treatment of Chronic Obstructive Pulmonary Disease
IWONA GRZELEWSKA-RZYMOWSKA

Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality throughout the world. In the paper the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendation are presented. The GOLD report points out that tobacco smoking is a major cause of COPD. The author describes clinical and spirometric characteristics of COPD and a pharmacological approach to the treatment of that disease. According to the GOLD report, patients with mild COPD should be treated with short-acting inhaled ?2-agonists and/or anticholinergic drugs as needed. Long-acting ?2-agonists (salmeterol, formoterol) and long-acting anticholinergic (tiotropium bromide) drugs are recommended for the treatment of moderate and severe COPD, while in severe COPD cases this therapy should be supplemented with treatment with inhaled glucocorticosteroids.

keywords: przewlekła oburacyjna choroba płuc, ?2-agoniści, wziewne glikokortykosteroidy, chronic obstructive pulmonary disease, β2-agonists, inhaled glucocorticosteroids

pages: from 188 to 194



estimated time of download (129 kB)
broadband speed:561282565121024[kbps]
time:279532[sec]


You need to have Adobe Acrobat Reader to view the PDF file. It's free. If you don't have the Adobe Acrobat Reader plugin yet, you can get it HERE.


Start page | Journals | Books | Conferences | News | Mediton | Contact

Copyright © 1996-2020 Mediton Publishing House | All rights reserved.